Previous 10 | Next 10 |
DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it will rep...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Rigetti (NASDAQ: RGTI ) stock is getting a boost on Friday after the company revealed it found new partners for its quantum computing efforts. First up is a partnership with Bluefors . ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: NYCStock / Shutterstock.com Esports Entertainment (NASDAQ: GMBL ) stock is falling hard on Friday after the company revealed public stock offering details . The latest press release has Esports Entert...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: iQoncept / Shutterstock Nabriva Therapeutics (NASDAQ: NBRV ) stock caught the attention of traders on Friday after shares surged in price this morning. However, not all is as it seems. While shares of ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com We’re starting off the final trading day of the week with a look at the biggest pre-market stock movers for Friday! Moving shares this morning are reverse stock splits, an as...
3 Penny Stocks to Add to Your Watchlist Today When it comes to trading penny stocks, there are a lot of aspects that go into it. You need to have a firm understanding of the market, what penny stocks are worth investing in, and how to make money off of them. However, if you’r...
Biopharmaceutical company Nabriva Therapeutics ( NASDAQ: NBRV ) is set to effect a 1-for-25 reverse stock split, effective for trading purposes on the Nasdaq Capital Market as of Sep. 16. The company's shareholders approved the stock split at the annual general meeting of ...
DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it w...
DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Ted Schroe...
DUBLIN, Ireland and FORT WASHINGTON, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced the completion of pati...
News, Short Squeeze, Breakout and More Instantly...
Nabriva Therapeutics plc Company Name:
NBRV Stock Symbol:
NASDAQ Market:
-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To Continue Work With Torreya Capital On Asset Monetization- DUBLIN, Ireland, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV) today announced that, after an assessment ...
- PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects – - Results Support Potential Utility of Lefamulin in Patients with Cystic Fibrosis - DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Na...
- Shifted Focus to SIVEXTRO to Enable Cost Cutting - - Cash Runway Extended into Q1 2023 - - Q3 2022 Total Revenue of $9.2 Million - - Engaged Torreya Capital As Strategic Advisor - - Conference call today at 4:30 p.m. Eastern Time - DUBLIN, Ireland, ...